文献速递临床免疫临床生化

胰岛素自身免疫综合征中C肽免疫反应性增高源于高分子量胰岛素原

Increased C-Peptide Immunoreactivity in Insulin Autoimmune Syndrome (Hirata Disease) Due to High Molecular Weight Proinsulin.
PubMed 文献 · Clin Chem · 2021-01-01

本研究探讨胰岛素自身免疫综合征(IAS)患者C肽免疫反应性增高的分子基础。通过聚乙二醇沉淀、液相色谱-串联质谱(LC-MS/MS)和凝胶过滤色谱分析,发现IAS血浆免疫复合物中富含胰岛素原和des 31,32胰岛素原而非C肽,提示某些C肽免疫测定中胰岛素原交叉反应可导致C肽结果假性升高。

要点

  • IAS患者血浆C肽免疫反应性增高可能为胰岛素原交叉反应所致的假性升高。
  • 聚乙二醇沉淀可区分免疫球蛋白结合的C肽免疫反应性。
  • 疑诊IAS时,C肽结果需结合临床并考虑交叉反应干扰。

核心结论

  • IAS免疫复合物中抗体结合可富集胰岛素原和des 31,32胰岛素原,导致某些C肽免疫测定出现假性升高的C肽结果。

研究设计与样本

  • 研究采用聚乙二醇沉淀血浆后行C肽免疫测定,溶剂沉淀提取血浆肽段后用nano-LC-MS/MS非靶向数据依赖方法分析,并以凝胶过滤色谱联用LC-MS/MS鉴定IAS免疫复合物中的胰岛素原相关肽,结果与C肽免疫测定比较。

主要发现

  • 聚乙二醇沉淀IAS血浆而非对照血浆可去除C肽免疫反应性,提示免疫球蛋白结合的C肽免疫反应性。
  • LC-MS/MS检测到IAS血浆中胰岛素原和des 31,32胰岛素原丰度高于对照血浆。
  • 凝胶过滤色谱联用LC-MS/MS显示IAS血浆免疫复合物中存在胰岛素原和des 31,32胰岛素原,但无C肽。

临床怎么用

  • 检验科医生在解释IAS患者C肽结果时,应意识到胰岛素原交叉反应可能导致C肽假性升高,避免误判为内源性胰岛素分泌过多。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Determination of C-peptide is important in the investigation of unexplained hyperinsulinemic hypoglycemia because a high C-peptide concentration usually indicates endogenous insulin hypersecretion. Insulin autoimmune syndrome (IAS) denotes hyperinsulinemic hypoglycemia due to insulin-binding antibodies that prolong insulin half-life. C-peptide clearance is considered to be unaffected, and although a marked C-peptide immunoreactivity in hypoglycemic samples has been reported, it has been suspected to be artifactual. High-resolution mass spectrometry enables examination of the basis of C-peptide-immunoreactivity in IAS. METHODS: Precipitation of plasma with polyethylene glycol was followed by C-peptide immunoassay. Plasma peptides extracted by solvent precipitation were characterized by nano-LC-MS/MS and analyzed using an untargeted data-dependent method. Peptides related to proinsulin, in amino acid sequence, were identified using proprietary bioinformatics software and confirmed by repeat LC-MS/MS analysis. Gel filtration chromatography coupled to LC-MS/MS was used to identify proinsulin-related peptides present in IAS immunocomplexes. Results were compared with those from C-peptide immunoassay. RESULTS: Polyethylene glycol precipitation of IAS plasma, but not control plasma, depleted C-peptide immunoreactivity consistent with immunoglobulin-bound C-peptide immunoreactivity. LC-MS/MS detected proinsulin and des 31,32 proinsulin at higher abundance in IAS plasma compared with control plasma. Analysis by gel filtration chromatography coupled to LC-MS/MS demonstrated proinsulin and des 31,32 proinsulin, but no C-peptide, in plasma immunocomplexes. CONCLUSIONS: Antibody binding can enrich proinsulin and des 31,32 proinsulin in IAS immunocomplexes. Proinsulin cross-reactivity in some C-peptide immunoassays can lead to artifactually increased C-peptide results.

来源:Clin Chem,查看原文。版权归原作者所有。

引用

  1. Kay RG, Barker P, Burling K, et al. Increased C-Peptide Immunoreactivity in Insulin Autoimmune Syndrome (Hirata Disease) Due to High Molecular Weight Proinsulin. Clin Chem. 2021. PMID: 34051096. doi:10.1093/clinchem/hvab043

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。